Advertisement
Mr. Liao joined the Company in March 2008, and had served in variouscapacities before being appointed to the role of CFO on May 7, 2008. Mr. YukunZhang, Financial Manager, will serve as interim CFO, and Ms. Yanwei Zhang,secretary to Mr. Yan-qing Liu, will serve as interim Board Secretary until asuccessor for Mr. Liao is named.
Advertisement
"Mr. Liao has been a valuable member of our team and we appreciate hisstrong contribution and all he has accomplished, especially his efforts inensuring the Company's successful migration to the American Stock Exchange,"said Mr. Yan-qing Liu, Chairman, CEO and President of China Sky One Medical,Inc. "Given our strong growth, we plan to explore our options as we conduct athorough search for a replacement for Mr. Liao who will meet our rigorouscriteria."
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is engaged in themanufacturing, marketing and distribution of pharmaceutical, medicinal anddiagnostic kit products. Through its wholly-owned subsidiaries, Harbin Tian DiRen Medical Science and Technology Company ("TDR") and Harbin First Bio-Engineering Company Limited ("First"), the Company manufactures anddistributes over-the-counter pharmaceutical products as its primary revenuesource. For more information, visit http://www.skyonemedical.com .
Safe Harbor Statement
Certain statements made in this press release constitute forward-lookingstatements within the meaning of the Private Securities Litigation Reform Actof 1995. These statements can be identified by the use of forward-lookingterminology such as "believe," "expect," "may," "will," "should," "project,""plan," "seek," "intend," or "anticipate" or the negative thereof orcomparable terminology. Such statements typically involve risks anduncertainties and may include financial projections or information regardingour future plans, objectives or performance. The Company cannot provide anyassurance that its application to list on the American Stock Exchange will beapproved or that the liquidity and marketability of its shares will improve.Actual results could differ materially from the expectations reflected in suchforward-looking statements as a result of a variety of factors, including theinability of the company to meet the listing standards, risks associated withthe effect of changing economic conditions in The People's Republic of China,variations in cash flow, reliance on collaborative retail partners and on newproduct development, variations in new product development, risks associatedwith rapid technological change, and the potential of introduced or undetectedflaws and defects in products, and other risk factors detailed in reportsfiled with the Securities and Exchange Commission from time to time.For more information, please contact: China Sky One Medical, Inc. Mr. Yan-qing Liu Chairman, CEO & President Phone: +86-451-5399-4069 Email: [email protected] CCG Elite Investor Relations Inc. Mr. Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: [email protected] Website: http://www.ccgelite.com
SOURCE China Sky One Medical, Inc.
